USD 305.28
(2.54%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.65 Billion USD | 22.5% |
2022 | 1.35 Billion USD | -18.52% |
2021 | 1.65 Billion USD | 19.36% |
2020 | 1.39 Billion USD | 21.66% |
2019 | 1.14 Billion USD | 18.09% |
2018 | 967.93 Million USD | 1.81% |
2017 | 950.71 Million USD | -2.9% |
2016 | 979.1 Million USD | -0.5% |
2015 | 984.04 Million USD | -10.29% |
2014 | 1.09 Billion USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 2.08 Billion USD | 8.54% |
2024 Q2 | 1.92 Billion USD | 6.92% |
2024 Q1 | 1.79 Billion USD | 8.39% |
2023 Q1 | 1.39 Billion USD | 3.2% |
2023 Q3 | 1.48 Billion USD | 5.67% |
2023 Q4 | 1.65 Billion USD | 11.44% |
2023 FY | 1.65 Billion USD | 22.5% |
2023 Q2 | 1.4 Billion USD | 0.8% |
2022 Q1 | 1.34 Billion USD | -19.01% |
2022 Q4 | 1.35 Billion USD | 1.81% |
2022 Q2 | 1.31 Billion USD | -2.15% |
2022 FY | 1.35 Billion USD | -18.52% |
2022 Q3 | 1.32 Billion USD | 0.99% |
2021 Q1 | 1.45 Billion USD | 4.36% |
2021 FY | 1.65 Billion USD | 19.36% |
2021 Q4 | 1.65 Billion USD | 5.25% |
2021 Q3 | 1.57 Billion USD | 7.31% |
2021 Q2 | 1.46 Billion USD | 1.26% |
2020 Q3 | 1.29 Billion USD | 6.06% |
2020 FY | 1.39 Billion USD | 21.66% |
2020 Q4 | 1.39 Billion USD | 7.29% |
2020 Q2 | 1.22 Billion USD | 7.43% |
2020 Q1 | 1.13 Billion USD | -0.48% |
2019 Q3 | 1.07 Billion USD | 5.45% |
2019 Q1 | 1 Billion USD | 3.99% |
2019 Q4 | 1.14 Billion USD | 6.6% |
2019 FY | 1.14 Billion USD | 18.09% |
2019 Q2 | 1.01 Billion USD | 1.03% |
2018 Q4 | 967.93 Million USD | 1.9% |
2018 Q2 | 968.18 Million USD | -0.5% |
2018 Q1 | 973.02 Million USD | 2.35% |
2018 FY | 967.93 Million USD | 1.81% |
2018 Q3 | 949.84 Million USD | -1.89% |
2017 Q3 | 948.87 Million USD | -1.53% |
2017 Q2 | 963.64 Million USD | -0.25% |
2017 Q4 | 950.71 Million USD | 0.19% |
2017 FY | 950.71 Million USD | -2.9% |
2017 Q1 | 966.09 Million USD | -1.33% |
2016 Q1 | 993.99 Million USD | 1.01% |
2016 Q4 | 979.1 Million USD | 0.27% |
2016 Q3 | 976.48 Million USD | -1.85% |
2016 FY | 979.1 Million USD | -0.5% |
2016 Q2 | 994.86 Million USD | 0.09% |
2015 Q1 | - USD | 0.0% |
2015 FY | 984.04 Million USD | -10.29% |
2015 Q4 | 984.04 Million USD | 0.0% |
2014 FY | 1.09 Billion USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aspira Women's Health Inc. | 6.26 Million USD | -26358.448% |
bioAffinity Technologies, Inc. | 8.22 Million USD | -20052.253% |
Intelligent Bio Solutions Inc. | 13.77 Million USD | -11924.417% |
Standard BioTools Inc. | 323.06 Million USD | -412.843% |
Inotiv, Inc. | 856.53 Million USD | -93.435% |
Prenetics Global Limited | 254.17 Million USD | -551.857% |
Neuronetics, Inc. | 115.83 Million USD | -1330.384% |
Star Equity Holdings, Inc. | 86.97 Million USD | -1804.969% |
Castle Biosciences, Inc. | 477.81 Million USD | -246.754% |
Psychemedics Corporation | 13.27 Million USD | -12385.516% |
RadNet, Inc. | 2.88 Billion USD | 42.605% |
Exact Sciences Corporation | 6.47 Billion USD | 74.397% |
IDEXX Laboratories, Inc. | 3.25 Billion USD | 49.176% |
iSpecimen Inc. | 15.81 Million USD | -10373.568% |
OpGen, Inc. | 1.88 Million USD | -87922.679% |
Exagen Inc. | 56.94 Million USD | -2809.574% |
Bionano Genomics, Inc. | 214.4 Million USD | -672.76% |
CareDx, Inc | 484.61 Million USD | -241.885% |
Check-Cap Ltd. | 25.01 Million USD | -6522.808% |
Twist Bioscience Corporation | 776.4 Million USD | -113.398% |
Guardant Health, Inc. | 1.78 Billion USD | 7.254% |
Biodesix, Inc. | 99.09 Million USD | -1571.942% |
BioNexus Gene Lab Corp. | 11.39 Million USD | -14433.843% |
Precipio, Inc. | 18.1 Million USD | -9053.24% |
Natera, Inc. | 1.45 Billion USD | -13.705% |
Fulgent Genetics, Inc. | 1.27 Billion USD | -30.14% |
Sera Prognostics, Inc. | 95.44 Million USD | -1635.971% |
23andMe Holding Co. | 395.16 Million USD | -319.273% |
OPKO Health, Inc. | 2.01 Billion USD | 17.64% |
Personalis, Inc. | 225.09 Million USD | -636.044% |
Aclaris Therapeutics, Inc. | 197.4 Million USD | -739.304% |
Applied DNA Sciences, Inc. | 13.65 Million USD | -12036.532% |
T2 Biosystems, Inc. | 34.79 Million USD | -4661.41% |
Neogen Corporation | 4.58 Billion USD | 63.858% |
Myriad Genetics, Inc. | 1.19 Billion USD | -38.219% |
ICON Public Limited Company | 16.98 Billion USD | 90.248% |
NeoGenomics, Inc. | 1.68 Billion USD | 1.451% |
Star Equity Holdings, Inc. | 86.97 Million USD | -1804.969% |
MDxHealth SA | 129.13 Million USD | -1183.05% |
Prenetics Global Limited | 254.17 Million USD | -551.857% |
Illumina, Inc. | 10.11 Billion USD | 83.614% |
DarioHealth Corp. | 96.38 Million USD | -1618.897% |
ENDRA Life Sciences Inc. | 6.75 Million USD | -24430.533% |
Mainz Biomed B.V. | 15.4 Million USD | -10652.32% |
Trinity Biotech plc | 59.43 Million USD | -2687.63% |
Sotera Health Company | 3.13 Billion USD | 47.073% |
bioAffinity Technologies, Inc. | 8.22 Million USD | -20052.253% |